Caren Mason is the President and CEO of STAAR Surgical Company, a role she has held since March 2015. Before leading STAAR, she was the CEO of Verinata Health from 2010 to 2012, a company that made non-invasive prenatal genetic...
Caren Mason is the President and CEO of STAAR Surgical Company, a role she has held since March 2015. Before leading STAAR, she was the CEO of Verinata Health from 2010 to 2012, a company that made non-invasive prenatal genetic tests. Prior to that, she spent several years at Quidel Corporation, where she was also CEO and transformed the company into a key player in rapid diagnostics. Caren's career includes significant roles at Eastman Kodak and General Electric Healthcare, giving her a broad perspective on the healthcare industry. One notable aspect of her compensation structure includes performance-based bonuses that connect her success to the company’s financial goals. For example, her total compensation in 2020 was over $1 million, with a good part tied to her performance metrics; she earned a target annual bonus based on achieving specific corporate financial objectives. Caren is also active on various boards, including that of the UC San Diego Moores Cancer Center, showing her ongoing commitment to healthcare improvement. She's not just about numbers; she has a history of innovation in the medical technology field.